Consulting I Technology I Staffing I Software I Training I Industries I Resources I News I About Us I Careers
Protect your patients and
your people, from
blueprints to the bedside.
We have solutions for the complete range of USP <797>
and <800> challenges in sterile compounding pharmacies
and healthcare facilities.
Sign up to receive the latest USP news!
Achieve Compliance
With the upcoming deadline for USP <797> and USP <800>, is your facility prepared?
We’re committed to your success.
Contact us today to assess your needs and get ahead of audits.
Visit us at Booth 415!
- WorkingBuildings and SafeBridge experts on hand to answer all your questions
- Enter to win a copy of ASHP's 5th edition textbook (just released): Compounding Sterile Preparations
- Join us for "Mingle and Master USP <797> and <800>, Tuesday at 3 pm at our booth. Enjoy cocktails and hors d'oeuvres while networking and learning insider's takes from our experts. RSVP here.
Our Process
We bring together a diverse team with decades of experience solving design and safety challenges in healthcare facilities, compounding pharmacies, and hazardous drug handling.
Professional mechanical engineers partner with a board-certified pharmacist to provide:
- Cleanroom gap analysis
- Expert cleanroom design, renovation, and remediation
- Cleanroom construction quality control
- Engineering commissioning services and downtime recovery testing
- Environmental monitoring support
- Workflow and SOP review and analysis
Our industrial hygienists and occupational toxicologists, with 25+ years of experience in hazardous drug (HD) safety, help you:
- Evaluate your HD list
- Evaluate potential exposure risk throughout the HD life cycle
- Develop surface sampling plans
- Establish health-based acceptable surface limits for HDs
- Recommend effective control strategies to protect worker health
- Communicate science-based solutions to staff
Our AIHA-accredited analytical laboratory can:
- Quantify up to 16 hazardous drugs in a single surface wipe sample
- Apply the most sensitive techniques in the industry to detect potent drugs at very low concentrations in the workplace
- But it doesn’t stop there: our industrial hygienists and occupational toxicologists can help you interpret the results, giving you the confidence to make data-driven decisions to protect worker safety.
The deadline is here. Have you addressed the full range of sterile compounding and HD program support?
Check out our video to see our comprehensive USP <797> and USP <800> services.
Your Team of Experts
Elaine Strauss, PharmD, MS, BCSCP
Senior Consultant, Cleanrooms and Sterile Compounding
Board-Certified Sterile Compounding Pharmacist
Amy H. Snow, MHS, CIH, CSP
Managing Industrial Hygienist
Chair, USP <800> Hazardous Drug Subcommittee, AIHA Healthcare Working Group
Janet Gould, Ph.D., DABT, CIH
Senior Principal Toxicologist
Member, USP <800> Hazardous Drug Subcommittee, AIHA Healthcare Working Group
F. Kurt Last
Executive Vice President, WorkingBuildings
Clinical Practice Leader, cGMP/GTP and USP <797>/<800>/<823>
Allan W. Ader, Ph.D., DABT
Managing Director, SafeBridge
Member, NIOSH Hazardous Drug Alert Committee, 2004
Kevin L. Tolleson CxA
Director, WorkingBuildings
Special Projects
Tony Martin, PE
Director, WorkingBuildings
Healthcare
Kent Rader
Manager, Business Development
Looking for more information?
Download our free resource, "Countdown to USP Compliance: 10 Things to Do Now"